Bacopa vs Gotu Kola: Which Is the Real Brahmi?
Bacopa vs gotu kola compared — which is the real brahmi? Memory RCTs, dosage by goal, safety, and the naming confusion explained.
Here's the confusion upfront: both bacopa and gotu kola have been called "brahmi" — in different regional traditions, on different product labels, and across half the internet. So when you search "brahmi for memory," you may be reading about either of two completely different plants. This guide settles the naming question first, then compares them: bacopa (Bacopa monnieri) with its bacosides and memory RCTs, versus gotu kola (Centella asiatica) with its triterpenes and circulation and wound-healing record.
Which One Is the Real Brahmi?
*Classically, "brahmi" means Bacopa monnieri. In the classical Ayurvedic texts, bacopa is brahmi and gotu kola is mandukaparni* — two distinct herbs (MDPI Nutrients 2013 narrative review; Ayurvedic Pharmacopoeia of India). The confusion arose because some regional traditions (particularly in North India) also sell gotu kola as "brahmi," and product labels have repeated the mix-up.
Practical consequences: a product labeled just "brahmi" could contain either plant — check the Latin name. Most modern memory research on "brahmi" studied Bacopa monnieri — buy gotu kola expecting bacopa's memory trials and you're buying the wrong evidence base. This site's library keeps them separate (brahmi-bacopa vs gotu-kola) for exactly this reason.
About Bacopa
Bacopa (Bacopa monnieri), the classical brahmi, is Ayurveda's foremost medhya rasayana — a rejuvenative for the mind. Its actives are bacosides (A and B), saponins believed to support neuronal communication and brain antioxidant defenses (Russo & Borrelli 2005 — preclinical data).
What the trials show: Bacopa has the stronger cognitive evidence base. Randomized, double-blind, placebo-controlled trials — notably the Australian trials by Stough and colleagues using a standardized extract (KeenMind/CDRI08) — reported improved learning rate and memory consolidation (AVLT) plus faster visual information processing, with maximal effects at 12 weeks (Stough et al. 2001, 300 mg/day KeenMind). A 2014 meta-analysis of nine RCTs (Kongkeaw et al., Journal of Ethnopharmacology) concluded bacopa 'has the potential to improve cognition, particularly speed of attention,' while noting high heterogeneity. The consistent theme: bacopa is slow — benefits build over 8–12 weeks, and short-term (single-dose) use shows little (Nathan et al. 2001). Caveat: effect sizes are modest, trials small by pharmaceutical standards, most used one specific standardized extract — and newer pooled evidence is mixed (Brimson et al. 2021; Lopresti & Smith 2025), so "modest and inconsistent" is the fairest overall read.
About Gotu Kola
Gotu kola (Centella asiatica) is a creeping marsh plant used across Ayurveda, TCM, and Southeast Asian medicine. Its actives are triterpenes — asiaticoside, madecassoside, asiatic/madecassic acids — and its traditional reputation centers on wound healing, circulation, and longevity rather than memory.
What the trials show: Gotu kola's strongest human evidence is in circulation and wound healing, not cognition. Trials of the total triterpenic fraction (TTFCA) report improved venous tone and reduced leg swelling/heaviness in chronic venous insufficiency (Pointel et al. 1987, 94 patients, TECA 60–120 mg/day × 2 months; Cesarone et al. 2001, TTFCA 120 mg/day × 8 weeks). Asiaticoside has trial support for wound-healing and scar outcomes (Paocharoen 2010 — 200 diabetic-foot-ulcer patients, 300 mg/day asiaticoside × 21 days; Saeidinia et al. — 75 burn patients, 3% topical Centella). Cognition: the data is much thinner — small trials suggest possible benefits, but nothing approaching bacopa's memory-trial record (Wattanathorn 2008 — n=28 healthy elderly, 750 mg/day extract × 2 months, working memory and mood gains; Puttarak et al. 2017 meta-analysis of 11 RCTs found no strong evidence for overall cognitive improvement).
The honest caveat: gotu kola is frequently sold for memory on the strength of the "brahmi" name confusion rather than its own cognitive evidence. Its real strengths lie elsewhere.
Head-to-Head Comparison
| *Bacopa (Bacopa monnieri)* | *Gotu Kola (Centella asiatica)* | |
|---|---|---|
| "Real brahmi"? | Yes — classical Ayurvedic brahmi (Ayurvedic Pharmacopoeia of India) | No — classical mandukaparni; "brahmi" only in some North Indian regional traditions |
| Primary actives | Bacosides A & B (saponins) | Triterpenes: asiaticoside, madecassoside |
| Memory evidence | Multiple RCTs; 8–12 week timeline; meta-analysis supports benefits (Stough 2001; Stough 2008; Kongkeaw 2014) | Thin — a 2017 meta-analysis of 11 RCTs found no strong evidence for overall cognitive improvement (Puttarak et al.) |
| Circulation / veins | Not a primary action | Best-studied use: venous insufficiency trials (TTFCA — Pointel 1987; Cesarone 2001) |
| Wound healing / skin | Limited | Trial support for wound-healing outcomes (Paocharoen 2010; Saeidinia et al.) |
| Anxiety / calm | Reduced state anxiety in trials (Stough 2001; Calabrese 2008) | Traditional use; limited modern trial data (Bradwejn 2000 — acoustic startle) |
| Onset timeline | Slow: 8–12 weeks for memory effects | Venous trials typically 6–8 weeks |
| Typical trial dose | 300 mg/day standardized extract (~55% bacosides, KeenMind/CDRI08 spec) | 60–120 mg/day triterpenes (TTFCA, venous trials); dried-leaf capsules/powders commonly 600–1,800 mg/day (LiverTox) |
| Side effects | GI upset (nausea, cramps, increased stool frequency) — the main trial complaints; generally well tolerated | Generally well tolerated; mild GI upset, headache; liver injury 'very rare' (LiverTox) |
| Pregnancy | Insufficient data — avoid without guidance | Oral use not recommended (Drugs.com; WebMD) |
| Best for | Memory, learning, mental clarity (with patience) | Circulation/leg veins, wound healing, skin |
Dosage Guide
Trial-based regimens, not prescriptions. Standardization matters — crude powder and extract doses are not interchangeable.
| Goal | Bacopa | Gotu Kola |
|---|---|---|
| Memory / cognition | 300 mg/day standardized extract (~55% bacosides, KeenMind/CDRI08 specification), 8–12+ weeks | Not the evidence-backed pick for memory |
| Circulation / venous | Not the pick | 60–120 mg/day total triterpenes (TTFCA, venous trials); dried-leaf capsules/powders commonly 600–1,800 mg/day (LiverTox) — not the trial form |
| Wound healing / skin | Limited evidence | Asiaticoside-containing extracts per trial protocols — e.g., 300 mg/day asiaticoside × 21 days (Paocharoen 2010); 3% topical Centella (Saeidinia et al.) |
| General calm / wellness | 300 mg/day standardized extract | Traditional tea or dried-leaf capsules (~600 mg/day range); the cognition trial used 250–750 mg/day of extract for 2 months (Wattanathorn 2008) |
| Sensitive stomach | Take with food; GI upset is the main complaint | Take with food |
Form notes: For bacopa, choose extracts standardized to not less than 55% bacosides (the KeenMind/CDRI08 specification used in the trials); unstandardized powders make trial doses meaningless. For gotu kola, TTFCA (total triterpenic fraction) is the studied form for venous outcomes — plain leaf powder is a different product (EMA/HMPC assessment EMA/HMPC/291177/2009).
Timing: Bacopa is typically taken with food (trial protocols varied; food minimizes the main complaint, GI upset). No trial has compared morning vs evening dosing — timing is personal preference. Gotu kola timing is less studied — with food is the safe default.
Safety & Interactions
Bacopa — well tolerated with a slow profile. Most common trial side effects: GI upset — nausea, abdominal cramps, increased stool frequency (Roodenrys 2002; Calabrese 2008; Kongkeaw 2014); dry mouth and fatigue are occasionally reported. Because cognitive effects need 8–12 weeks, the main "risk" is impatience. Theoretical interactions include additive effects with thyroid medication (animal data: bacopa raised serum T4 ~41% in male mice — Kar et al. 2002) and sedatives (preclinical GABAergic activity); interaction monographs classify both as theoretical — discuss with a pharmacist if you take either. One small 12-week trial in older adults noted a modest decrease in resting heart rate with bacopa (Calabrese et al. 2008); there is no evidence of clinically significant bradycardia.
Gotu kola — generally well tolerated, with a liver caveat. Mild GI upset and headache are the common complaints. Importantly, rare case reports link gotu kola to liver injury (three cases of severe hepatic injury including granulomatous hepatitis and cirrhosis, with positive rechallenge in two — Jorge & Jorge 2005; LiverTox calls hepatotoxicity "very rare") — stop use for jaundice, dark urine, or upper-right abdominal pain; anyone with liver disease should use it only under medical supervision. Conventional references (Drugs.com; WebMD) advise against oral use in pregnancy.
Cautious with either: pregnancy/breastfeeding (insufficient data for both), thyroid medication or sedatives (bacopa theoretical interactions — see above), liver disease (gotu kola case reports), and scheduled surgery (stop gotu kola at least 2 weeks before surgery per WebMD; discuss any herbal supplement with your surgeon before a scheduled procedure).
Which Should You Choose?
Check the Latin name on your product first — then match the herb to the goal:
- Memory, learning, or mental clarity → Bacopa: the only one with real memory RCTs. Commit to 8–12 weeks.
- Leg veins, heaviness, or circulation → Gotu kola (TTFCA form): its best-studied territory.
- Wound healing or skin support → Gotu kola: trial-backed; bacopa has little data here.
- Calm/focus without sedation → Bacopa has modest anxiolytic trial signals (Stough 2001; Calabrese 2008); gotu kola's calm data is mostly traditional.
- You bought "brahmi" for memory → Confirm it's Bacopa monnieri — if the label says Centella asiatica, you have gotu kola and the wrong evidence base for your goal.
Short version: bacopa is the memory herb; gotu kola is the circulation-and-skin herb — and "brahmi" on a label tells you nothing until you read the Latin name.
Can You Take Them Together?
Traditional formulations sometimes combine medhya herbs (classical medhya rasayana formulations include both Bacopa monnieri and Centella asiatica), and the two have different primary actions (cognitive vs circulatory). But no large human trials were found on the bacopa + gotu kola combination (PubMed check Sep 2026; only a 2025 comparative bacopa-vs-gotu-kola RCT in children and a 2025 mouse study of a combined formulation exist), and gotu kola's rare liver-injury reports mean stacking deserves clinician awareness. If combined, use standardized forms of each and introduce them separately.
❓ Frequently Asked Questions
📢 Disclaimer: This information is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any new supplement. Sources are linked for verification.
📚 Clinical Research & Sources
- Stough C et al. "The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects." *Psychopharmacology (Berl).* 2001;156(4):481–484. PMID 11498727. 300 mg KeenMind/day × 12 weeks; improved learning rate and memory consolidation (AVLT), visual information processing speed (IT), and state anxiety; maximal effects at 12 weeks.[Source ↗]
- Stough C et al. "Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial." *Phytother Res.* 2008;22(12):1629–1634. PMID 18683852. 300 mg/day (2×150 mg) × 90 days; improved working memory, fewer RVIP false positives.[Source ↗]
- Kongkeaw C et al. "Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract." *J Ethnopharmacol.* 2014;151(1):528–535. PMID 24252493. Conclusion: "has the potential to improve cognition, particularly speed of attention"; high heterogeneity.[Source ↗]
- Pointel JP et al. "Titrated extract of Centella asiatica (TECA) in the treatment of venous insufficiency of the lower limbs." *Angiology.* 1987;38(1):46–50[Source ↗]
- Paocharoen 2010 — 200 diabetic-foot-ulcer patients; 300 mg/day asiaticoside × 21 days vs placebo; accelerated wound contraction, suppressed scarring — plus Saeidinia et al.[Source ↗]
- Wattanathorn J et al. "Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica." *J Ethnopharmacol.* 2008;116(2):325–332. PMID 18191355.[Source ↗]
- Jorge OA, Jorge AD. "Hepatotoxicity associated with the ingestion of Centella asiatica." *Rev Esp Enferm Dig.* 2005;97(2):115–124[Source ↗]
- MDPI Nutrients 2013;5(2):478[Source ↗]
- Examine.com summary of bacopa evidence — notes newer pooled evidence is mixed: Brimson et al. *Sci Rep* 2021 meta-analysis and Lopresti & Smith 2025 RCT (PMID 41091332) found no clinically meaningful between-group cognitive differences.[Source ↗]
Explore the Full Remedy Database
Browse 500+ organic alternatives for health, wellness, and natural living.
Browse All Remedies →